Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02210559
What this trial is testing

Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer (Unresectable)
Kyntra Bio 37
Early research (Phase 1)Ended earlyNCT03825289
What this trial is testing

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CarcinomaStage II Pancreatic CancerStage IIA Pancreatic Cancer+4 more
University of Utah 25
Not applicableStudy completedNCT03962478
What this trial is testing

Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction

Who this might be right for
Pancreatic CarcinomaBiliary Obstruction
Xuzhou Central Hospital 92
Testing effectiveness (Phase 2)UnknownNCT03636308
What this trial is testing

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Peking University 40
Not applicableUnknownNCT01448668
What this trial is testing

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Who this might be right for
Pancreas Cancer
IFAG AG 220
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)UnknownNCT06078787
What this trial is testing

Olaparib in PALB2 Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Modena 16
Early research (Phase 1)Study completedNCT01469793
What this trial is testing

DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Genentech, Inc. 71
Testing effectiveness (Phase 2)Study completedNCT00652366
What this trial is testing

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 467
Not applicableStudy completedNCT03622229
What this trial is testing

EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle

Who this might be right for
Biopsy, Fine-needlePancreatic Neoplasm
Azienda Ospedaliera Universitaria Integrata Verona 192
Early research (Phase 1)Study completedNCT00001431
What this trial is testing

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Who this might be right for
Gastrointestinal NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 20
Not applicableUnknownNCT01919151
What this trial is testing

Micrometastasis in Gastrointestinal Cancer

Who this might be right for
Pancreatic AdenocarcinomaColorectal Cancer
Oslo University Hospital 500
Not applicableUnknownNCT05095831
What this trial is testing

EUS Shear Wave for Solid Pancreatic Lesions.

Who this might be right for
Pancreas NeoplasmPancreatitisPancreatitis, Acute+2 more
Instituto Ecuatoriano de Enfermedades Digestivas 25
Not applicableNot Yet RecruitingNCT07448376
What this trial is testing

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Who this might be right for
CTCsPancreatic CancerLiver Metastases+4 more
Huazhong University of Science and Technology 20
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Not applicableUnknownNCT05248750
What this trial is testing

Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreas Cancer
Catholic University of the Sacred Heart 250
Not applicableStudy completedNCT00548626
What this trial is testing

Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Chicago 47
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531291
What this trial is testing

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

Who this might be right for
ESCCBiliary Tract CancerGastric Cancer+1 more
RenJi Hospital 80
Not applicableUnknownNCT06539806
What this trial is testing

Clinical Study Evaluating the Effect of Losartan

Who this might be right for
Pancreatic Cancer
Tanta University 90
Next Page